Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Contract Manufacturing: $1,419M in FY2025, up 23.2% from a year earlier.
Latest, FY2025
1,419
Period ended Dec 31, 2025
Change on a year earlier
+23.2%
1,152 in FY2024
History
5 years
Since FY2021
Sources
4
Documents cited below
Where the FY2025 figure comes from
“|| Contract manufacturing | 1 419 | 1 152 | 23 | 19”
Source: Novartis Form 6-K (0001114448-26-000007) ↗
Reported in Form 6-K & Form 20-F.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Contract Manufacturing ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1,419 | +23.2% | Novartis Form 6-K (0001114448-26-000007) ↗ |
| FY2024 | Dec 31, 2024 | 1,152 | -22.7% | Novartis Form 6-K (0001114448-26-000007) ↗ |
| FY2023 | Dec 31, 2023 | 1,490 | +24.2% | Novartis Form 6-K (0001370368-25-000007) ↗ |
| FY2022 | Dec 31, 2022 | 1,200 | +1,011.1% | Novartis Form 6-K (0001370368-24-000007) ↗ |
| FY2021 | Dec 31, 2021 | 108 | – | Novartis Form 6-K (0001370368-23-000008) ↗ |
Breakdown
What makes up contract Manufacturing
Cite this data
StockData. (2026). Novartis Contract Manufacturing ($M), annual FY2021–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/brand-contract-manufacturing
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.